280 related articles for article (PubMed ID: 29795290)
1. Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer's disease by interacting with APOE ε4.
Zhang A; Zhao Q; Xu D; Jiang S
Sci Rep; 2018 May; 8(1):8068. PubMed ID: 29795290
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
Jiang S; Yang W; Qiu Y; Chen HZ;
Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
[TBL] [Abstract][Full Text] [Related]
3. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
4. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
7. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
Xue S; Jia L; Jia J
Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
[TBL] [Abstract][Full Text] [Related]
8. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
[TBL] [Abstract][Full Text] [Related]
9. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
[TBL] [Abstract][Full Text] [Related]
10. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.
Haasl RJ; Ahmadi MR; Meethal SV; Gleason CE; Johnson SC; Asthana S; Bowen RL; Atwood CS
BMC Med Genet; 2008 Apr; 9():37. PubMed ID: 18439297
[TBL] [Abstract][Full Text] [Related]
11. CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.
Li L; Yin Z; Liu J; Li G; Wang Y; Yan J; Zhou H
J Neurol; 2013 Jul; 260(7):1701-8. PubMed ID: 23070465
[TBL] [Abstract][Full Text] [Related]
12. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
[TBL] [Abstract][Full Text] [Related]
13. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN
Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755
[TBL] [Abstract][Full Text] [Related]
14. Age, APOE and sex: Triad of risk of Alzheimer's disease.
Riedel BC; Thompson PM; Brinton RD
J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
[TBL] [Abstract][Full Text] [Related]
15. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.
Chen DW; Yang JF; Tang Z; Dong XM; Feng XL; Yu S; Chan P
Brain Res; 2008 Jan; 1187():52-7. PubMed ID: 18036514
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
[TBL] [Abstract][Full Text] [Related]
17. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
[TBL] [Abstract][Full Text] [Related]
18. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity.
de Waal H; Stam CJ; de Haan W; van Straaten EC; Blankenstein MA; Scheltens P; van der Flier WM
Neurobiol Aging; 2013 Sep; 34(9):2158-63. PubMed ID: 23587637
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.
Koo KYG; Schweizer TA; Fischer CE; Munoz DG
Curr Alzheimer Res; 2019; 16(3):243-250. PubMed ID: 30605058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
